Treatment of post-transplant recurrent FSGS in children using plasmapheresis and augmentation of immunosuppression

BACKGROUND: Up to 60% of pediatric renal transplant recipients with end-stage renal disease due to primary focal and segmental glomerulosclerosis (FSGS) may develop recurrent disease. Such recurrence is associated with poor prognosis if no remission is achieved. We report a single center experience...

Descripción completa

Detalles Bibliográficos
Autores principales: Restrepo, Jaime M., Torres-Canchala, Laura, Londoño, Hernando, Manzi, Eliana, Somers, Michael J. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981666/
https://www.ncbi.nlm.nih.gov/pubmed/35382760
http://dx.doi.org/10.1186/s12882-022-02768-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981666/
https://www.ncbi.nlm.nih.gov/pubmed/35382760
http://dx.doi.org/10.1186/s12882-022-02768-w

Ejemplares similares